FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34791011000001104: Mavenclad 10mg tablets (Merck Serono Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105291601000001119 Mavenclad 10mg tablets (Merck Serono Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105291701000001112 Mavenclad 10mg tablets (Merck Serono Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mavenclad 10mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Is a Cladribine 10mg tablets true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has active ingredient Cladribine true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has specific active ingredient Cladribine true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Is a Mavenclad true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mavenclad 10mg tablets (Merck Serono Ltd) 4 tablet Has AMP True Mavenclad 10mg tablets (Merck Serono Ltd) Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) 1 tablet Has AMP True Mavenclad 10mg tablets (Merck Serono Ltd) Inferred relationship Existential restriction modifier
Mavenclad 10mg tablets (Merck Serono Ltd) 6 tablet Has AMP True Mavenclad 10mg tablets (Merck Serono Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start